Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · IEX Real-Time Price · USD
75.13
+0.27 (0.35%)
Jul 22, 2024, 10:13 AM EDT - Market open
Intra-Cellular Therapies Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$94.83
Upside
+26.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $94 → $100 | Strong Buy | Maintains | $94 → $100 | +33.11% | Jul 22, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $85 → $83 | Strong Buy → Hold | Downgrades | $85 → $83 | +10.48% | Jun 25, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $103 | Buy | Reiterates | $103 | +37.10% | Jun 25, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $96 → $100 | Strong Buy | Maintains | $96 → $100 | +33.11% | Jun 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $107 → $113 | Strong Buy | Maintains | $107 → $113 | +50.42% | Jun 20, 2024 |
| Needham | Needham | Strong Buy Maintains $90 → $94 | Strong Buy | Maintains | $90 → $94 | +25.12% | Jun 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $120 | Buy | Reiterates | $120 | +59.73% | Jun 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $75 → $78 | Buy | Maintains | $75 → $78 | +3.83% | Jun 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +19.80% | May 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +19.80% | May 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $120 | Buy | Reiterates | $120 | +59.73% | Apr 24, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $100 → $107 | Strong Buy | Maintains | $100 → $107 | +42.43% | Apr 23, 2024 |
| Needham | Needham | Strong Buy Maintains $82 → $90 | Strong Buy | Maintains | $82 → $90 | +19.80% | Apr 22, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $82 → $96 | Strong Buy | Maintains | $82 → $96 | +27.79% | Apr 22, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $67 → $77 | Hold | Maintains | $67 → $77 | +2.50% | Apr 17, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $82 → $91 | Strong Buy | Maintains | $82 → $91 | +21.13% | Apr 17, 2024 |
| Baird | Baird | Buy Maintains $83 → $103 | Buy | Maintains | $83 → $103 | +37.10% | Apr 17, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $80 → $90 | Strong Buy | Maintains | $80 → $90 | +19.80% | Apr 17, 2024 |
| Needham | Needham | Strong Buy Reiterates $82 | Strong Buy | Reiterates | $82 | +9.15% | Apr 16, 2024 |
| Needham | Needham | Strong Buy Reiterates $82 | Strong Buy | Reiterates | $82 | +9.15% | Apr 5, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $86 | Buy | Reiterates | $86 | +14.48% | Apr 3, 2024 |